France – Produits pharmaceutiques – Fourniture complémentaire de médicaments biosimilaires et génériques
AI summary
This tender concerns a supplementary supply of biosimilar and generic medicines to Nantes University Hospital Centre. The procurement aims to ensure continued availability of cost-effective pharmaceutical products for patient care and hospital operations.
Pharmaceutical wholesalers, distributors, or manufacturers with authorization to supply medicinal products in France and proven experience in biosimilar and generic medicine distribution should bid.
Suppliers must be authorized pharmaceutical distributors or manufacturers capable of delivering biosimilar and generic medicines that comply with French and EU pharmaceutical regulations and quality standards.
Frequently asked questions
What is this tender about?
This tender concerns a supplementary supply of biosimilar and generic medicines to Nantes University Hospital Centre. The procurement aims to ensure continued availability of cost-effective pharmaceutical products for patient care and hospital operations.
What are the requirements for suppliers?
Suppliers must be authorized pharmaceutical distributors or manufacturers capable of delivering biosimilar and generic medicines that comply with French and EU pharmaceutical regulations and quality standards.
What type of company should bid?
Pharmaceutical wholesalers, distributors, or manufacturers with authorization to supply medicinal products in France and proven experience in biosimilar and generic medicine distribution should bid.
Who is the buyer?
The buyer is Centre Hospitalier Universitaire de Nantes.
Fourniture complémentaire de médicaments biosimilaires et génériques
Documents not listed
Fourniture complémentaire de médicaments biosimilaires et génériques
- PriceTechnique 45% - Logistique 10% - Prix 45%
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…